IK acquires German pharma group Aposan

The investment was made via IK Small Cap I Fund. In March this year, the GP held a final close on €277m for its small-cap vehicle, hitting the hard-cap after one year on the road.

The GP said in a statement it will look to grow the business organically and via selective add-on acquisitions.

Company
Aposan has three business segments: pharmaceutical homecare, providing services to patients that require long-term infusion therapy to treat diseases; classical homecare, providing standard enteral nutrition as well as selected standard medical devices; and ophthalmic injectables. Aposan currently services 10,000 patients a year.

The group was founded in 1991 by Clemens Künzer, who will retain a share in the company. CEO Rainer Schmitz, CSO Michael Schmitz and COO Claudia Vitiello will also become shareholders investing alongside Kunzer and IK.

People
IK Investment Partners – Anders Petersson (partner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• DACH
• Healthcare
• IK Investment Partners